Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment

摘要

Background We attempted to determine the preferences of women regarding the benefits they considered necessary to make adjuvant therapy worthwhile, and to compare preferences for adjuvant endocrine therapy, chemotherapy, and trastuzumab therapy. We also investigated the effect of information about cost on women’s treatment preferences.